Professor Robert Field will be covering the U.S. Supreme Court Myriad Genetics case on behalf of the Philadelphia Inquirer today.
Field, a nationally recognized expert on health policy, previously discussed the case, which involves whether the biotech firm, Myriad Genetics, which obtained patents for two genes associated with breast cancer and a test that determines the presence of mutations linked to the disease, can retain those patents.
Field has covered major Supreme Court cases for the Inquirer before, most recently . The Inquirer also hosts Field's health law and policy blog, , to which 3L Erica Cohen contributes.